{"id":"W2809024048","doi":"10.1016/j.ejca.2018.05.002","title":"Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer","year":2018,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hospital for Sick Children","funders":"Celgene","keywords":"Medicine; Neutropenia; Leukopenia; Rhabdomyosarcoma; Refractory (planetary science); Sarcoma; Internal medicine; Response Evaluation Criteria in Solid Tumors; Paclitaxel; Adverse effect; Chemotherapy; Progressive disease; Cancer; Gastroenterology; Surgery; Oncology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001884835,0.001203295,0.001724937,0.0003543666,0.000472275,0.0009415142,0.0009465032,0.001064143,0.002723471],"category_scores_gemma":[0.001356853,0.0005120175,0.001402259,0.0004677628,0.0008378425,0.0006193193,0.0003751474,0.003200105,0.0006288034],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001174544,"about_ca_system_score_gemma":0.002970133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002949626,"about_ca_topic_score_gemma":0.006548782,"domain_scores_codex":[0.9994872,0.0002875017,0.00002760713,0.00005913277,0.00003871141,0.00009983571],"domain_scores_gemma":[0.9987444,0.0002050999,0.000245197,0.0001230291,0.0001033091,0.0005789764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6102805,0.09319181,0.01973906,0.001120413,0.00313683,0.0007330104,0.0009599336,0.006284793,0.08293574,0.0006033829,0.01213545,0.1688792],"study_design_scores_gemma":[0.5771998,0.3768294,0.02543279,0.00008674136,0.001508559,0.0008394567,0.0001834253,0.001150712,0.007665214,0.000298303,0.008756103,0.00004937512],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883749,0.002863567,0.0009363837,0.0007943227,0.0001175051,0.003101147,0.00194984,0.00008580797,0.001776561],"genre_scores_gemma":[0.9699975,0.006670802,0.006682238,0.001474115,0.0002101888,0.00503553,0.006913007,0.0001336915,0.002882834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002949626,"threshold_uncertainty_score":0.009968042,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01968340602350789,"score_gpt":0.3521808022629326,"score_spread":0.3324973962394248,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}